Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials.

Saved in:
Bibliographic Details
Title: Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials.
Authors: Hallemeier CL; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Moughan J; NRG Oncology Statistics and Data Management Center/American College of Radiology, Philadelphia, Pennsylvania., Haddock MG; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Herskovic AM; Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois., Minsky BD; Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston., Suntharalingam M; Department of Radiation Oncology, University of Maryland and Greenebaum Comprehensive Cancer Center, Baltimore., Zeitzer KL; Department of Radiation Oncology, Albert Einstein Medical Center, Philadelphia, Pennsylvania., Garg MK; Department of Radiation Oncology, Montefiore Medical Center-Moses Campus, Bronx, New York., Greenwald BD; Department of Gastroenterology and Hepatology, University of Maryland and Greenebaum Cancer Center, Baltimore., Komaki RU; Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston., Puckett LL; Department of Radiation Oncology, Medical College of Wisconsin and Zablocki Veterans' Administration Medical Center, Milwaukee., Kim H; Department of Radiation Oncology, Washington University School of Medicine in St Louis, St Louis, Missouri., Lloyd S; Department of Radiation Oncology, University of Utah Health Science Center, Salt Lake City., Bush DA; Department of Radiation Oncology, Loma Linda University Cancer Institute, Loma Linda, California., Kim HE; Department of Radiation Oncology, Wayne State University/Karmanos Cancer Institute, Detroit, Michigan., Lad TE; Department of Medical Oncology, John H. Stroger Jr Hospital of Cook County, Chicago, Illinois., Meyer JE; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Okawara GS; Department of Radiation Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, Ontario, Canada., Raben A; Department of Radiation Oncology, Christiana Care Health Services Inc Community Clinical Oncology Program, Newark, Delaware., Schefter TE; Department of Radiation Oncology, University of Colorado, Aurora., Barker JL Jr; Department of Radiation Oncology, US Oncology Texas Oncology-Sugar Land, Fort Worth., Falkson CI; Department of Medicine, Hematology/Oncology, University of Rochester, Rochester, New York., Videtic GMM; Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio., Jacob R; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham., Winter KA; NRG Oncology Statistics and Data Management Center/American College of Radiology, Philadelphia, Pennsylvania., Crane CH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Source: JAMA network open [JAMA Netw Open] 2023 Apr 03; Vol. 6 (4), pp. e238504. Date of Electronic Publication: 2023 Apr 03.
Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2574-3805
DOI:10.1001/jamanetworkopen.2023.8504